Speech-Language Pathology

Therapies and Managing Daily Life

At a Glance

Management of Microduplication Xp11.22p11.23 syndrome is individualized: speech and communication therapy, physical and occupational therapy, school accommodations, behavioral strategies, and clinician-guided constipation care support daily function and independence.

Because Microduplication Xp11.22p11.23 does not have a “one-size-fits-all” treatment, management is phenotype-driven. This means your child’s care is built around their specific strengths and challenges rather than a generic checklist. The goal of therapy is not to “fix” the duplication, but to maximize your child’s independence and quality of life ^[1]^[2].

Communication and Speech Therapy

Speech challenges are frequently reported, often involving expressive language delay (difficulty using words) or dysarthria (weakness in the muscles used for speech) ^[1]^[3].

Speech-Language Pathology (SLP): Therapy should focus on functional communication. If your child is struggling to speak, ask about Augmentative and Alternative Communication (AAC). This can include anything from picture boards to high-tech tablets with speech-generating apps ^[4].
AAC Myths: Research shows that using AAC does not “stop” a child from learning to speak; in many cases, it actually supports language development by reducing frustration and providing a clear model for communication ^[5]^[6].
Aided Language Modeling: At home, you can support your child by using their communication system yourself while you talk to them. This “modeling” helps them understand how to use the tool to express their own thoughts ^[4]^[7].

Motor Skills and Daily Activity

Delays in motor skills and exercise intolerance (tiring easily) have been noted ^[1].

Physical and Occupational Therapy (PT/OT): Therapy should be function-oriented. Instead of just practicing repetitive exercises, focus on goals that matter to your daily life, such as safely navigating stairs, participating in playground activities, or mastering self-care like dressing ^[8]^[9].
Managing Fatigue: If your child tires easily, work with their PT to find a balance between building strength and preventing exhaustion. This might involve “pacing” activities or using adaptive equipment for longer outings ^[1]^[10].

Behavioral and Educational Support

Traits associated with ADHD and autism spectrum disorder (ASD) are reported and can impact school and social life ^[2]^[11].

Individualized Education Program (IEP): Ensure your child’s school plan includes accommodations for their specific needs, such as extra time for tasks, visual schedules, and access to their communication device ^[12]^[13].
Behavioral Strategies: Predictable routines and visual supports (like “First/Then” boards) can help manage the anxiety or transitions that often come with ASD and ADHD ^[14]^[15].
Medication Monitoring: It is important to clarify that no medication treats the core social-communication differences of autism. However, medications may be prescribed for co-occurring symptoms like severe irritability, ADHD symptoms, anxiety, or sleep problems. Prescribers generally follow a “start low and go slow” approach. Monitoring for side effects—such as appetite loss, sleep disruption, or changes to a seizure threshold—is vital ^[16].

Managing Chronic Constipation

Constipation is a physical symptom noted in some individuals with this duplication ^[1].

The Maintenance Plan: If lifestyle changes like fiber and water aren’t enough, doctors often recommend long-term maintenance with an osmotic laxative like polyethylene glycol (PEG 3350) ^[17]^[18].
Realistic Expectations: The dose, need for disimpaction, and duration depend on the child. Do not change treatment without your clinician. Tapering is usually considered after sustained symptom resolution ^[19]^[20].
Red Flags: Seek urgent medical assessment for severe or progressive abdominal pain/distension, green/bilious vomiting, dehydration, blood in the stool, fever, or inability to pass stool or gas ^[17]^[18].

Daily management is a marathon, not a sprint. By focusing on your child’s functional goals and staying consistent with supportive therapies, you can help them navigate the unique challenges of Xp11.22p11.23.

Common questions in this guide

What treatments are used for Microduplication Xp11.22p11.23 syndrome?

There is no single treatment that fits every child. Care is tailored to individual needs and may include speech-language therapy, communication tools, physical and occupational therapy, school accommodations, behavioral strategies, and clinician-guided constipation care.

Could an AAC device stop my child from learning to speak?

No. Augmentative and alternative communication, such as picture boards or speech-generating tablets, can reduce frustration and give a child another way to communicate while speech develops. A speech-language pathologist can help select and use the right system.

How can we safely manage exercise intolerance in our child?

A physical therapist can help balance activity that builds strength with rest that prevents exhaustion. Pacing, adapted activities, and assistive equipment may help the child participate safely at school, during play, and on longer outings.

What school supports can help with ADHD or autism-related traits?

An individualized education program may include extra time, visual schedules, predictable routines, and access to a communication device. Visual tools such as First/Then boards can also make transitions and expectations easier to understand.

How is constipation usually managed in children with this syndrome?

Fiber and fluids may help, but a clinician may recommend polyethylene glycol, also called PEG 3350, when lifestyle changes are not enough. Some children need a clinician-directed stool-clearing step before maintenance treatment, and the dose and duration should not be changed without medical guidance.

When does constipation require urgent medical attention?

Seek urgent assessment for severe or worsening abdominal pain or swelling, green vomiting, dehydration, blood in the stool, fever, or inability to pass stool or gas. These symptoms can signal a problem needing prompt medical evaluation.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Microduplication Xp11.22p11.23 syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Should we pursue a formal evaluation for Augmentative and Alternative Communication (AAC), and how can we integrate it into our child's existing speech therapy?
2.Given the potential for exercise intolerance, how can we adapt physical education or recreational activities to keep my child active safely?
3.If behavioral medications are considered, how will we monitor for side effects like appetite changes, sleep issues, or impacts on a seizure threshold?
4.Is my child currently impacted with stool, and if so, what is the specific medical plan for 'disimpaction' before starting maintenance?
5.Can you help us define three 'participation-based' goals for PT/OT, such as independently climbing stairs or dressing?

Key takeaways

Treatment for Microduplication Xp11.22p11.23 syndrome is individualized to the child's communication, motor, behavioral, educational, and daily-living needs.
Speech-language therapy and AAC, including picture boards or speech-generating devices, can support communication without preventing speech development.
Physical and occupational therapy should use participation-based goals, pacing, and adaptive equipment when fatigue or exercise intolerance limits activity.
Individualized education program accommodations, visual supports, predictable routines, and clinician-monitored medicines can address school needs and co-occurring symptoms, but medicines do not treat autism's core social-communication differences.
Constipation may require clinician-guided stool clearing and maintenance treatment such as PEG 3350, with urgent evaluation for severe pain, swelling, vomiting, dehydration, blood, fever, or inability to pass stool or gas.

References (20)

1
Genotype-phenotype characterization in 13 individuals with chromosome Xp11.22 duplications.
Grams SE, Argiropoulos B, Lines M, et al.
American journal of medical genetics. Part A 2016; (170A(4)):967-77 doi:10.1002/ajmg.a.37519.
PMID: 26692240
2
Duplication Xp11.22-p14 in females: does X-inactivation help in assessing their significance?
Evers C, Mitter D, Strobl-Wildemann G, et al.
American journal of medical genetics. Part A 2015; (167A(3)):553-62 doi:10.1002/ajmg.a.36897.
PMID: 25691408
3
Xp11.22 duplications in four unrelated Chinese families: delineating the genotype-phenotype relationship for HSD17B10 and FGD1.
Wang Q, Chen P, Liu J, et al.
BMC medical genomics 2020; (13(1)):66 doi:10.1186/s12920-020-0728-8.
PMID: 32381089
4
Effects of Interventions That Include Aided Augmentative and Alternative Communication Input on the Communication of Individuals With Complex Communication Needs: A Meta-Analysis.
O'Neill T, Light J, Pope L
Journal of speech, language, and hearing research : JSLHR 2018; (61(7)):1743-1765 doi:10.1044/2018_JSLHR-L-17-0132.
PMID: 29931287
5
External challenges for individuals who need or use AAC who are learning language: lived experiences, key research findings, and future directions.
Holyfield C, Light J, Nieder D, Preece J
Augmentative and alternative communication (Baltimore, Md. : 1985) 2025; (41(3)):267-279 doi:10.1080/07434618.2025.2508485.
PMID: 40439166
6
Participant characteristics predicting communication outcomes in AAC implementation for individuals with ASD and IDD: a systematic review and meta-analysis.
Ganz JB, Pustejovsky JE, Reichle J, et al.
Augmentative and alternative communication (Baltimore, Md. : 1985) 2023; (39(1)):7-22 doi:10.1080/07434618.2022.2116355.
PMID: 36262108
7
Overcoming barriers to literacy for individuals who need or use AAC: lived experiences, key research findings, and future directions.
Light J, Holyfield C, McNaughton D, et al.
Augmentative and alternative communication (Baltimore, Md. : 1985) 2025; (41(3)):283-294 doi:10.1080/07434618.2025.2502032.
PMID: 40396965
8
ICF-inspired goal-setting in developmental rehabilitation: an innovative framework for pediatric therapists.
Angeli JM, Schwab SM, Huijs L, et al.
Physiotherapy theory and practice 2021; (37(11)):1167-1176 doi:10.1080/09593985.2019.1692392.
PMID: 31766925
9
Patient-Centered Goal Setting in Developmental Therapy: Discordance between Documented Goals and Caregiver-Perceived Goals.
Angeli JM, Harpster K, Huijs L, et al.
Pediatric quality & safety 2019; (4(4)):e199 doi:10.1097/pq9.0000000000000199.
PMID: 31572900
10
How do parents frame their engagement experience in early intervention? A grounded theory study.
Harniess PA, Basu AP, Bezemer J, Gibbs D
Disability and rehabilitation 2024; (46(14)):3067-3076 doi:10.1080/09638288.2023.2242788.
PMID: 37652081
11
Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders.
Moey C, Hinze SJ, Brueton L, et al.
European journal of human genetics : EJHG 2016; (24(3)):373-80 doi:10.1038/ejhg.2015.123.
PMID: 26059843
12
School dysfunction in youth with autistic spectrum disorder in Taiwan: The effect of subtype and ADHD.
Chiang HL, Kao WC, Chou MC, et al.
Autism research : official journal of the International Society for Autism Research 2018; (11(6)):857-869 doi:10.1002/aur.1923.
PMID: 29427542
13
Visual attention and academic performance in children with developmental disabilities and behavioural attention deficits.
Kirk HE, Gray K, Riby DM, et al.
Developmental science 2017; (20(6)) doi:10.1111/desc.12468.
PMID: 27649816
14
Children and adolescents with neurodevelopmental disorders show cognitive heterogeneity and require a person-centered approach.
Márquez-Caraveo ME, Rodríguez-Valentín R, Pérez-Barrón V, et al.
Scientific reports 2021; (11(1)):18463 doi:10.1038/s41598-021-97551-6.
PMID: 34531454
15
Classification, prevalence and integrated care for neurodevelopmental and child mental health disorders: A brief overview for paediatricians.
Ogundele MO, Morton M
World journal of clinical pediatrics 2022; (11(2)):120-135 doi:10.5409/wjcp.v11.i2.120.
PMID: 35433298
16
Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder in Individuals with Autism Spectrum Disorder.
Joshi G, Wilens TE
Child and adolescent psychiatric clinics of North America 2022; (31(3)):449-468 doi:10.1016/j.chc.2022.03.012.
PMID: 35697395
17
Paediatrics: how to manage functional constipation.
Leung AK, Hon KL
Drugs in context 2021; (10()) doi:10.7573/dic.2020-11-2.
PMID: 33828605
18
Management of Childhood Functional Constipation: Consensus Practice Guidelines of Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition and Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics.
Yachha SK, Srivastava A, Mohan N, et al.
Indian pediatrics 2018; (55(10)):885-892.
PMID: 29941697
19
Psychiatric Features of Children with Chronic Functional Constipation: Focusing on Individuals with Autism Spectrum Disorder.
Akama F, Mikami K, Orihashi Y, et al.
Journal of autism and developmental disorders 2025; (55(2)):585-591 doi:10.1007/s10803-023-06228-8.
PMID: 38265573
20
Management of Functional Constipation in Children: Therapy in Practice.
Koppen IJ, Lammers LA, Benninga MA, Tabbers MM
Paediatric drugs 2015; (17(5)):349-60 doi:10.1007/s40272-015-0142-4.
PMID: 26259965

This page is for informational purposes only and does not constitute medical advice for your child. Discuss AAC, activity, behavioral medicines, and constipation treatment with your child’s clinicians before making changes.

Guide Contents